Walgreens Boots Alliance (NASDAQ:WBA) posted its quarterly earnings data on Thursday. The pharmacy operator reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.03, Morningstar.com reports. The business had revenue of $33.79 billion during the quarter, compared to the consensus estimate of $33.90 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.28 earnings per share. Walgreens Boots Alliance updated its FY 2019 guidance to $6.44-6.74 EPS and its FY19 guidance to $6.40-6.70 EPS.
Shares of NASDAQ WBA opened at $73.29 on Thursday. Walgreens Boots Alliance has a twelve month low of $59.07 and a twelve month high of $86.31. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. The stock has a market capitalization of $71.39 billion, a price-to-earnings ratio of 12.17, a price-to-earnings-growth ratio of 1.18 and a beta of 0.76.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th were issued a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date was Thursday, November 8th. Walgreens Boots Alliance’s payout ratio is 29.24%.
In other Walgreens Boots Alliance news, SVP Kimberly R. Scardino sold 11,970 shares of the business’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $79.79, for a total transaction of $955,086.30. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the business’s stock in a transaction dated Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total value of $4,096,040.00. Following the sale, the executive vice president now owns 81,076 shares in the company, valued at approximately $6,386,356.52. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock valued at $5,824,194 over the last three months. 15.73% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Asset Dedication LLC increased its holdings in shares of Walgreens Boots Alliance by 204.6% in the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after purchasing an additional 1,060 shares during the period. BlueMountain Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at about $103,000. CSat Investment Advisory L.P. acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at about $104,000. Capital Advisors Ltd. LLC increased its holdings in shares of Walgreens Boots Alliance by 1,150.3% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock valued at $150,000 after purchasing an additional 1,898 shares during the period. Finally, Livingston Group Asset Management CO operating as Southport Capital Management acquired a new position in Walgreens Boots Alliance in the third quarter worth approximately $154,000. Hedge funds and other institutional investors own 62.82% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance (WBA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS” was first posted by WKRB News and is the property of of WKRB News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.wkrb13.com/2018/12/20/walgreens-boots-alliance-wba-announces-quarterly-earnings-results-beats-expectations-by-0-03-eps.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.